Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Revenue Recognition Changed
8
Jan 09, 2008 01:09PM

Jan 09, 2008 01:54PM
17
Jan 09, 2008 02:39PM
2
Jan 09, 2008 03:30PM

This revised 10Q language is very interesting.  I believe the company is saying two things:

1) some license agreements (perhaps the J settlement licenses confirmed in the 10Q) after Nov. 30 may be different from those implemented previously.  I suspect some type of ongoing payments vs. the one-time payment.

2) due to this "highly interpretive area of accounting" it has not yet been determined precisely how the revenues from these revised agreements will be recognized.


Jan 09, 2008 05:03PM
7
Jan 09, 2008 07:28PM
Share
New Message
Please login to post a reply